Chapter/Section Purchase

1 Study Coverage
1.1 Crigler-Najjar Syndrome Drug Product Introduction
1.2 Global Crigler-Najjar Syndrome Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Crigler-Najjar Syndrome Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Crigler-Najjar Syndrome Drug Sales in Volume for the Year 2017-2028
1.3 United States Crigler-Najjar Syndrome Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Crigler-Najjar Syndrome Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Crigler-Najjar Syndrome Drug Sales in Volume for the Year 2017-2028
1.4 Crigler-Najjar Syndrome Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Crigler-Najjar Syndrome Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Crigler-Najjar Syndrome Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Crigler-Najjar Syndrome Drug Market Dynamics
1.5.1 Crigler-Najjar Syndrome Drug Industry Trends
1.5.2 Crigler-Najjar Syndrome Drug Market Drivers
1.5.3 Crigler-Najjar Syndrome Drug Market Challenges
1.5.4 Crigler-Najjar Syndrome Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Crigler-Najjar Syndrome Drug Market Segment by Type
2.1.1 ALXN-1540
2.1.2 AT-342
2.1.3 HepaStem
2.1.4 Others
2.2 Global Crigler-Najjar Syndrome Drug Market Size by Type
2.2.1 Global Crigler-Najjar Syndrome Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Crigler-Najjar Syndrome Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Crigler-Najjar Syndrome Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Crigler-Najjar Syndrome Drug Market Size by Type
2.3.1 United States Crigler-Najjar Syndrome Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Crigler-Najjar Syndrome Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Crigler-Najjar Syndrome Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Crigler-Najjar Syndrome Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Crigler-Najjar Syndrome Drug Market Size by Application
3.2.1 Global Crigler-Najjar Syndrome Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Crigler-Najjar Syndrome Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Crigler-Najjar Syndrome Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Crigler-Najjar Syndrome Drug Market Size by Application
3.3.1 United States Crigler-Najjar Syndrome Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Crigler-Najjar Syndrome Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Crigler-Najjar Syndrome Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Crigler-Najjar Syndrome Drug Competitor Landscape by Company
4.1 Global Crigler-Najjar Syndrome Drug Market Size by Company
4.1.1 Top Global Crigler-Najjar Syndrome Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Crigler-Najjar Syndrome Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Crigler-Najjar Syndrome Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Crigler-Najjar Syndrome Drug Price by Manufacturer (2017-2022)
4.2 Global Crigler-Najjar Syndrome Drug Concentration Ratio (CR)
4.2.1 Crigler-Najjar Syndrome Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Crigler-Najjar Syndrome Drug in 2021
4.2.3 Global Crigler-Najjar Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Crigler-Najjar Syndrome Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Crigler-Najjar Syndrome Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Crigler-Najjar Syndrome Drug Product Type
4.3.3 Date of International Manufacturers Enter into Crigler-Najjar Syndrome Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Crigler-Najjar Syndrome Drug Market Size by Company
4.5.1 Top Crigler-Najjar Syndrome Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Crigler-Najjar Syndrome Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Crigler-Najjar Syndrome Drug Sales by Players (2020, 2021 & 2022)
5 Global Crigler-Najjar Syndrome Drug Market Size by Region
5.1 Global Crigler-Najjar Syndrome Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Crigler-Najjar Syndrome Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Crigler-Najjar Syndrome Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Crigler-Najjar Syndrome Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Crigler-Najjar Syndrome Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Crigler-Najjar Syndrome Drug Sales in Value by Region: 2017-2022
5.3.2 Global Crigler-Najjar Syndrome Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Crigler-Najjar Syndrome Drug Market Size YoY Growth 2017-2028
6.1.2 North America Crigler-Najjar Syndrome Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Crigler-Najjar Syndrome Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Crigler-Najjar Syndrome Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Crigler-Najjar Syndrome Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Crigler-Najjar Syndrome Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Crigler-Najjar Syndrome Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Crigler-Najjar Syndrome Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Crigler-Najjar Syndrome Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Crigler-Najjar Syndrome Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Audentes Therapeutics Inc
7.1.1 Audentes Therapeutics Inc Corporation Information
7.1.2 Audentes Therapeutics Inc Description and Business Overview
7.1.3 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Products Offered
7.1.5 Audentes Therapeutics Inc Recent Development
7.2 Genethon SA
7.2.1 Genethon SA Corporation Information
7.2.2 Genethon SA Description and Business Overview
7.2.3 Genethon SA Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Genethon SA Crigler-Najjar Syndrome Drug Products Offered
7.2.5 Genethon SA Recent Development
7.3 International Stem Cell Corp
7.3.1 International Stem Cell Corp Corporation Information
7.3.2 International Stem Cell Corp Description and Business Overview
7.3.3 International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 International Stem Cell Corp Crigler-Najjar Syndrome Drug Products Offered
7.3.5 International Stem Cell Corp Recent Development
7.4 Promethera Biosciences SA
7.4.1 Promethera Biosciences SA Corporation Information
7.4.2 Promethera Biosciences SA Description and Business Overview
7.4.3 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Products Offered
7.4.5 Promethera Biosciences SA Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Crigler-Najjar Syndrome Drug Industry Chain Analysis
8.2 Crigler-Najjar Syndrome Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Crigler-Najjar Syndrome Drug Distributors
8.3 Crigler-Najjar Syndrome Drug Production Mode & Process
8.4 Crigler-Najjar Syndrome Drug Sales and Marketing
8.4.1 Crigler-Najjar Syndrome Drug Sales Channels
8.4.2 Crigler-Najjar Syndrome Drug Distributors
8.5 Crigler-Najjar Syndrome Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer